I will be (annoyingly) cryptic, but I heard from 2 sources that the right people are cautiously optimistic about the GSK/TEVA development (heard it this morning, before the Markman article).
Is he still a friend, LOL? I avoid rec'ing stocks to people IRL because I don't want them getting mad at me if something like AMRN losing the patent case happens.